关于术后凝血异常的案例报告
Hongjing Zhou1, Yanyan Tang1, Yongtian Zhang1
1Jining No. 1 People's Hospital, Jining, Shandong, China.
Medicine
|January 5, 2024
概括
手术后的内动脉瘤手术可能导致罕见的狼抗凝剂诱导的凝血功能障碍. 早期识别和治疗调整对于患者的康复和改善结果至关重要.
科学领域:
- 神经外科 神经外科
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 内动脉瘤 (IA) 是大脑动脉局部扩张,通常通过手术治疗.
- 手术后并发症很常见,但异常的凝血功能,特别是由于狼抗凝药,很少见.
研究的目的:
- 为了调查在内动脉瘤手术后出现的一种罕见的术后凝血功能障碍病例.
- 探索狼抗凝剂在神经外科手术后获得的凝血障碍中的作用.
- 讨论与狼抗凝剂诱导的凝血病相关的诊断和治疗挑战.
主要方法:
- 一名69岁的女性患者被诊断患有IA出血,接受了切除术.
- 手术后的症状包括昏迷和发烧,最初的凝血指标正常.
- 对于感染和凝血支持 (因子,血) 的标准治疗是无效的.
- 进一步的调查显示,存在狼抗凝剂.
主要成果:
- 患者在IA的头骨切除术后表现出异常的凝血功能.
- 最初的治疗,包括凝血因子补充和血输液,未能纠正凝血病.
- 狼抗凝剂的检测提供了一个新的诊断和治疗方向.
- 根据狼抗凝剂的鉴定而调整治疗计划,导致凝血指数的逐步改善.
结论:
- 在内动脉瘤手术后的术后异常凝血功能可能是罕见但显著的.
- 在神经外科手术后出现不明原因的凝血病时,应考虑使用狼抗凝剂.
- 及时识别和有针对性的治疗调整对于管理与狼抗凝剂相关的凝血障碍至关重要.
- 早期识别狼抗凝剂可以指导适当的治疗策略,并改善患者的治疗结果.
相关概念视频
01:24Disorders of Hemostasis
922
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
922
01:20Extrinsic and Intrinsic Pathways of Hemostasis
7.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.8K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
702
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
702